Company GENinCode Plc

Equities

GENI

GB00BL97B504

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Ratings for GENinCode Plc

EPS Revisions

Annual profits - Rate of surprise

Sector Diagnostic & Testing Substances

Market Closed - London S.E. Other stock markets 09:05:16 09/05/2024 pm IST			5-day change	1st Jan Change
9.25 ^GBX	+2.78%		+25.42%	+76.19%

04/04	GENinCode Plc Announces Publication by the American Journal of Preventive Cardiology of A Study on 'Polygenic Risk and Incident Heart Disease in a Large Multiethnic Cohort	CI
21/03	GENinCode says ROCA recommended as ovarian cancer risk test in England	AN

GENinCode Plc is a United Kingdom-based predictive genetics company. The Company is engaged in the risk assessment, prediction, and prevention of cardiovascular disease (CVD). Its tests include Cardio Incode, Lipid Incode, Sudd Incode, Roca Test, Thrombo and Thrombo Incode Reproductive Health. The Company's product portfolio draws on advanced genomic precision testing using polygenic (multiple genes) technology, molecular testing, genotyping, sequencing, and AI bioinformatics to risk assess patient DNA. Its predictive technology provides patients and physicians with global preventative care and treatment strategies. Its products combine genetic and clinical data to risk-assess patients and provide healthcare practitioners with advanced clinical information to evaluate and predict the onset of cardiovascular disease. The Companyâs wholly owned subsidiaries include GENinCode S.L.U. and GENinCode U.S. INC.

Number of employees: 34

GBP in Million	2021	Weight	2022	Weight	Delta
Clinical Genetics Tests 100.0 %	1	100.0 %	1	100.0 %	+23.92%

GBP in Million	2021	Weight	2022	Weight	Delta
Spain 84.4 %	1	86.7 %	1	84.4 %	+20.58%
Italy 9.2 %	0	8.2 %	0	9.2 %	+38.95%
United Kingdom 2.5 %	-	-	0	2.5 %	-
France 2.5 %	0	2.8 %	0	2.5 %	+12.50%
Chile 0.4 %	0	0.7 %	0	0.4 %	-25.00%
Mexico 0.4 %	-	-	0	0.4 %	-
Peru 0.4 %	0	0.5 %	0	0.4 %	0.00%
Sweden 0.1 %	0	0.3 %	0	0.1 %	-75.00%

Managers	Title	Age	Since
Matthew Walls FOU	Founder	60	06/18/06
Jordi Gilberte FOU	Founder	49	06/18/06
Paul Foulger DFI	Director of Finance/CFO	55	01/20/01

Members of the board	Title	Age	Since
Paul Foulger DFI	Director of Finance/CFO	55	01/20/01
Matthew Walls FOU	Founder	60	06/18/06
William Rhodes CHM	Chairman	70	01/21/01
Felix Frueh BRD	Director/Board Member	56	06/22/06
Huon Gray BRD	Director/Board Member	-	21/22/21
Jordi Gilberte FOU	Founder	49	06/18/06
Sergio Rigau BRD	Director/Board Member	63	01/20/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	176,964,426	101,155,198 ( 57.16 %)	0	57.16 %

Name	Equities	%	Valuation
Octopus Investments Ltd. 17.66 %	31,255,672	17.66 %	3 M p
Santi 1990 SL 11.41 %	20,190,182	11.41 %	2 M p
Jordi Puig 8.252 %	14,602,500	8.252 %	1 M p
Jordi Gilberte 8.184 %	14,482,500	8.184 %	1 M p
Matthew Walls 6.647 %	11,762,500	6.647 %	1 M p
MATTIOLI WOODS PLC 6.010 %	10,635,672	6.010 %	923 708 p
Downing LLP 6.010 %	10,635,672	6.010 %	923 708 p
Foresight Group LLP 5.785 %	10,236,864	5.785 %	889 072 p
Maven Capital Partners UK LLP 5.746 %	10,168,758	5.746 %	883 157 p
Maitland Asset Management (Pty) Ltd. 4.784 %	8,465,154	4.784 %	735 199 p

GENinCode Plc

1, St. Peters Square

M2 3DE, Manchester

http://www.genincode.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
GENINCODE PLC	+76.19%	19.9M
BIOMÉRIEUX	-1.34%	12.58B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-1.64%	8.51B
DIASORIN S.P.A.	+0.09%	5.29B
LANTHEUS HOLDINGS, INC.	+22.42%	5.16B
AUTOBIO DIAGNOSTICS CO., LTD.	-0.09%	4.55B
10X GENOMICS, INC.	-52.84%	3.04B
ANDON HEALTH CO., LTD.	+20.02%	3B
MYRIAD GENETICS, INC.	+31.92%	2.17B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-2.45%	1.92B

Diagnostic & Testing Substances